In 2024, Medacta Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Medacta Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, the total operational greenhouse gas (GHG) emissions of Medacta Group amounted to 1,916 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medacta Group increased by 31.41%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2024, the total Scope 1 emissions of Medacta Group were 1,296 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2023), Medacta Group's Scope 1 emissions increased by 36.56%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2024, Medacta Group reported Scope 2 greenhouse gas (GHG) emissions of 321 tCOâ‚‚e using the market-based method, and 620 tCOâ‚‚e using the location-based method.
Compared to the previous year (2023), Medacta Group's Scope 2 emissions (Location-Based) rose by 21.81% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2024, Medacta Group reported its Scope 2 emissions using the market-based method and using the location-based method.